Sep 3, 2026 08:06AM
Sep 3, 2026 08:05AM
Aug 21, 2026 04:13PM
Aug 14, 2026 08:05AM
Aug 13, 2026 04:06PM
Aug 13, 2026 04:05PM
Aug 12, 2026 09:35AM Aptevo raises $4.5M through warrant exercise and private placement
Aug 12, 2026 09:30AM
Jul 27, 2026 08:06AM
Jul 27, 2026 08:05AM
Jun 30, 2026 08:06AM
Jun 30, 2026 08:05AM
May 28, 2026 08:05AM
May 28, 2026 08:05AM Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
May 27, 2026 08:05AM
May 27, 2026 08:05AM
May 13, 2026 08:07AM
May 13, 2026 08:05AM
May 6, 2026 08:10AM
May 6, 2026 08:05AM
Mar 26, 2026 08:05AM Aptevo Provides State of the Business Report and 2025 Financial Results
Mar 19, 2026 08:05AM
Mar 10, 2026 08:21AM
Mar 10, 2026 08:05AM
Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM
Jan 28, 2026 04:23PM
Jan 9, 2026 08:05AM Aptevo Therapeutics secures $60 million equity line of credit
Jan 9, 2026 08:05AM
Dec 26, 2025 08:05AM
Dec 26, 2025 08:05AM
Dec 9, 2025 08:07AM
Dec 9, 2025 08:05AM
Nov 10, 2025 08:05AM
Nov 10, 2025 08:05AM Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors
Nov 6, 2025 08:05AM
Oct 8, 2025 08:20AM
Oct 1, 2025 04:34PM
Sep 16, 2025 08:34AM
Sep 16, 2025 08:30AM
Sep 5, 2025 09:00AM
Sep 4, 2025 08:46AM Aptevo expands cancer pipeline with two trispecific drug candidates
Sep 4, 2025 08:45AM
Aug 13, 2025 08:06AM
Aug 13, 2025 08:05AM
Aug 11, 2025 10:53AM
Aug 11, 2025 08:05AM
Aug 8, 2025 09:00AM
Jul 25, 2025 04:18PM Aptevo Therapeutics (APVO) Files for 8.25M Share Offering by Selling Stockholders
Jun 20, 2025 11:30AM

460,508 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All